Predictive oncology appoints dr. bernard a. harris, jr. to its newly formed business advisory board

Eagan, minn., june 20, 2023 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, clinical laboratory improvement amendments (clia) laboratory and good manufacturing practices (gmp) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of dr. bernard a. harris, jr. to its newly-formed business advisory board (bab).
POAI Ratings Summary
POAI Quant Ranking